Review



bioactive compound library  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    TargetMol bioactive compound library
    Bioactive Compound Library, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 109 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Bioactive+Compound+Library/pmc10985106-204-9-14
    Average 97 stars, based on 109 article reviews
    bioactive compound library - by Bioz Stars, 2026-11
    97/100 stars

    Images

    Related Articles

    other:

    Article Title: Cell Painting in activated cells illuminates phenotypic dark space and drug mechanisms of action
    Article Snippet: We obtained a library of 8,387 bioactive compounds (L4000-CUST, listed in Supplementary Data 1) from TargetMol.

    Article Title: P2Y12-oriented computational screening and functional validation identify antiplatelet compounds with antithrombotic activity.
    Article Snippet: AutoDock Vina10 was used to dock the compound into the protein pocket and choose the best docking pose for the next analysis.

    Article Title: MD2-IN-1 restores microglial lysosomal function and attenuates amyloid pathology through TREM2-associated signaling in 5×FAD mice.
    Article Snippet: Triggering receptor expressed on myeloid cells 2 (TREM2) is a central regulator of microglial adaptation during Alzheimer’s disease (AD), yet the development of small-molecule modulators associated with TREM2 signaling remains limited.. Here, through a consensus pharmacophore-guided virtual screening strategy, MD2-IN-1 was identified as a candidate small molecule associated with TREM2 signaling.. Biolayer interferometry and cellular thermal shift assays supported cellular target engagement related to TREM2 (KD= 13.85 μM).

    Positive Control:

    Article Title: A Multifunctional Electrospun Membrane for Full-Thickness Abdominal Wall Defect Repair.
    Article Snippet: Electrospun nanofiber membranes hold promise for abdominal wall repair due to their biomimetic architecture and tunable properties.. However, their porous structure often induces an elevated foreign body response (FBR) that impedes tissue integration and remodeling.. While previous strategies have employed ibuprofen (IBU) to mitigate inflammation, its nonselective cyclooxygenase (COX) inhibition and rapid systemic clearance limit local therapeutic efficacy.

    Article Title: Use of pyrido[1,2-a]pyrimidone analogue
    Article Snippet: F12 Culture medium (purchased from Gibco, product number: 11765-054); (3) Test Article and Positive Control Article Test article: compound I; Positive control article: Cisplatin, molecular weight: 300.05; solvent: PBS (phosphate buffer saline); storage condition: 2-8° C.; supplier: Qilu Pharmaceutical. .. Positive control article: Alpelisib, molecular weight: 441.47; solvent: DMSO; supplier: Shanghai TOPSCIENCE Biochemical Technology Co., Ltd., CAS number: 1217486-61-7; 2. ..

    Membrane:

    Article Title: A Multifunctional Electrospun Membrane for Full-Thickness Abdominal Wall Defect Repair.
    Article Snippet: Electrospun nanofiber membranes hold promise for abdominal wall repair due to their biomimetic architecture and tunable properties.. However, their porous structure often induces an elevated foreign body response (FBR) that impedes tissue integration and remodeling.. While previous strategies have employed ibuprofen (IBU) to mitigate inflammation, its nonselective cyclooxygenase (COX) inhibition and rapid systemic clearance limit local therapeutic efficacy.

    Sterility:

    Article Title: A Multifunctional Electrospun Membrane for Full-Thickness Abdominal Wall Defect Repair.
    Article Snippet: Electrospun nanofiber membranes hold promise for abdominal wall repair due to their biomimetic architecture and tunable properties.. However, their porous structure often induces an elevated foreign body response (FBR) that impedes tissue integration and remodeling.. While previous strategies have employed ibuprofen (IBU) to mitigate inflammation, its nonselective cyclooxygenase (COX) inhibition and rapid systemic clearance limit local therapeutic efficacy.

    Molecular Weight:

    Article Title: Use of pyrido[1,2-a]pyrimidone analogue
    Article Snippet: F12 Culture medium (purchased from Gibco, product number: 11765-054); (3) Test Article and Positive Control Article Test article: compound I; Positive control article: Cisplatin, molecular weight: 300.05; solvent: PBS (phosphate buffer saline); storage condition: 2-8° C.; supplier: Qilu Pharmaceutical. .. Positive control article: Alpelisib, molecular weight: 441.47; solvent: DMSO; supplier: Shanghai TOPSCIENCE Biochemical Technology Co., Ltd., CAS number: 1217486-61-7; 2. ..

    Solvent:

    Article Title: Use of pyrido[1,2-a]pyrimidone analogue
    Article Snippet: F12 Culture medium (purchased from Gibco, product number: 11765-054); (3) Test Article and Positive Control Article Test article: compound I; Positive control article: Cisplatin, molecular weight: 300.05; solvent: PBS (phosphate buffer saline); storage condition: 2-8° C.; supplier: Qilu Pharmaceutical. .. Positive control article: Alpelisib, molecular weight: 441.47; solvent: DMSO; supplier: Shanghai TOPSCIENCE Biochemical Technology Co., Ltd., CAS number: 1217486-61-7; 2. ..

    Drug discovery:

    Article Title: Targeting the CD4 + effector memory T cells re-expressing CD45RA suppressor galectin-7: a multi-omics-guided therapeutic strategy for idiopathic pulmonary fibrosis.
    Article Snippet: .. A library of approximately 20,000 bioactive compounds (TargetMol Bioactive Compound Library) was prepared using the LigPrep module (Schrödinger, LLC, New York, NY, 2021). ..

    Article Title: Discovery of tepotinib as a novel LY75-targeting small-molecule inhibitor with anti-tumor activity in ovarian cancer via virtual screening
    Article Snippet: .. Preprocessing of the small-molecule library and virtual screening The commercially available TargetMol Bioactive Compound Library (L4000), containing 17,284 small molecules, was used in this study. ..

    Screening:

    Article Title: Discovery of tepotinib as a novel LY75-targeting small-molecule inhibitor with anti-tumor activity in ovarian cancer via virtual screening
    Article Snippet: .. Preprocessing of the small-molecule library and virtual screening The commercially available TargetMol Bioactive Compound Library (L4000), containing 17,284 small molecules, was used in this study. ..



    Similar Products

    99
    Illumina Inc illumina phix library
    Illumina Phix Library, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/pmc13750924-62-1-1
    Average 99 stars, based on 1 article reviews
    illumina phix library - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Illumina Inc illumina phix control library
    Illumina Phix Control Library, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/pmc13755692-134-13-13
    Average 99 stars, based on 1 article reviews
    illumina phix control library - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Illumina Inc thefinal libraries
    Thefinal Libraries, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/10__1038_slash_s41467___026___78240___2-463-0-5
    Average 99 stars, based on 1 article reviews
    thefinal libraries - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Illumina Inc phix library
    Phix Library, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/10__1007_slash_s40858___026___00851___3-111-16-18
    Average 99 stars, based on 1 article reviews
    phix library - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Illumina Inc phix control library
    Phix Control Library, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/10__1186_slash_s13287___026___05192___1-190-42-45
    Average 99 stars, based on 1 article reviews
    phix control library - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    97
    TargetMol positive control article
    Positive Control Article, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Bioactive+Compound+Library/us12661357-97-0-11
    Average 97 stars, based on 1 article reviews
    positive control article - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    97
    TargetMol positive control group
    Positive Control Group, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Bioactive+Compound+Library/pm42237667-88-1-24
    Average 97 stars, based on 1 article reviews
    positive control group - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    94
    TargetMol compounds cell survival against dmso control
    High-throughput phenotypic assay screening of heterogeneous, patient-derived GBM cell lines. (A) High content phenotypic assay screening workflow on GBM cells. Five libraries were screened at multiple <t>concentrations</t> <t>(C3L,</t> 786 compounds at [0.003, 0.03, 0.3, 3] µm; KCGS, 187 compounds at [0.1, 1] µm; LOPAC, 1277 compounds at [0.5, 3] µm; Prestwick, 1276 compounds at [1, 10] µm; TargetMol-330, 330 compounds at [0.01, 0.1, 1, 10] µm). (B) Representative images of multiplex cell painting assay screen performed across the three main GBM cellular subtypes: classical (GCGR-E13, GCGR-E28), proneural (GCGR-E31, GCGR-E34), and mesenchymal (GCGR-E21, GCGR-E57). The cell painting stains shown are Hoechst (blue), phalloidin/WGA (green), and endoplasmic reticulum (red). (C) Density plots over all six GBM cell lines of the percentage of nuclei counts after compound treatment with respect to the average <t>DMSO</t> negative control (100%) per plate. After removal of duplicates, the dataset contains 3561 unique compounds. Colours correspond to each library (panel A), and only the highest concentration per library is shown. Cell line sensitivity to the compounds is variable across the cell lines; the bimodality displayed by the TargetMol library reveals a larger fraction of compounds that affect cell viability as compared to the other four libraries. (D) Density plots of the TargetMol library screen at all concentrations of cell line GCGR-E57 (top) and of cell line GCGR-E21 (bottom). The black dotted line represents the average DMSO negative control nuclei count. As the concentration increases, a larger number of compounds affects cell viability.
    Compounds Cell Survival Against Dmso Control, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Autophagy+Compound+Library/pmc13181845-63-3-32
    Average 94 stars, based on 1 article reviews
    compounds cell survival against dmso control - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    97
    TargetMol positive control entry inhibitor
    (a) Percent inhibition of <t>entry</t> into HEK 293T/T17 and (b) relative cell viability with 22f treatment against pseudotyped (PT) MLVs expressing NWA GPCs for JUNV, MACV, GTOV, or TCRV. Viral entry results represent the percent reduction in entry by 22f compared to the vehicle <t>control.</t> Cytotoxicity was determined in parallel by measuring the viability of treated cells using the CellTiter-Glo Luminescent Cell Viability Assay, with luminescence units normalized to the average vehicle control luminescence for each experiment. The 22f compound was well tolerated by cells, exhibiting a toxicity profile comparable to that of the ch128.1 <t>positive-control</t> antibody treatment. Data shown are the means ± SD from two separate experiments for each pseudotyped virus. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.
    Positive Control Entry Inhibitor, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Bioactive+Compound+Library/pmc13270517-195-24-21
    Average 97 stars, based on 1 article reviews
    positive control entry inhibitor - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    Image Search Results


    High-throughput phenotypic assay screening of heterogeneous, patient-derived GBM cell lines. (A) High content phenotypic assay screening workflow on GBM cells. Five libraries were screened at multiple concentrations (C3L, 786 compounds at [0.003, 0.03, 0.3, 3] µm; KCGS, 187 compounds at [0.1, 1] µm; LOPAC, 1277 compounds at [0.5, 3] µm; Prestwick, 1276 compounds at [1, 10] µm; TargetMol-330, 330 compounds at [0.01, 0.1, 1, 10] µm). (B) Representative images of multiplex cell painting assay screen performed across the three main GBM cellular subtypes: classical (GCGR-E13, GCGR-E28), proneural (GCGR-E31, GCGR-E34), and mesenchymal (GCGR-E21, GCGR-E57). The cell painting stains shown are Hoechst (blue), phalloidin/WGA (green), and endoplasmic reticulum (red). (C) Density plots over all six GBM cell lines of the percentage of nuclei counts after compound treatment with respect to the average DMSO negative control (100%) per plate. After removal of duplicates, the dataset contains 3561 unique compounds. Colours correspond to each library (panel A), and only the highest concentration per library is shown. Cell line sensitivity to the compounds is variable across the cell lines; the bimodality displayed by the TargetMol library reveals a larger fraction of compounds that affect cell viability as compared to the other four libraries. (D) Density plots of the TargetMol library screen at all concentrations of cell line GCGR-E57 (top) and of cell line GCGR-E21 (bottom). The black dotted line represents the average DMSO negative control nuclei count. As the concentration increases, a larger number of compounds affects cell viability.

    Journal: Digital Discovery

    Article Title: Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models

    doi: 10.1039/d5dd00190k

    Figure Lengend Snippet: High-throughput phenotypic assay screening of heterogeneous, patient-derived GBM cell lines. (A) High content phenotypic assay screening workflow on GBM cells. Five libraries were screened at multiple concentrations (C3L, 786 compounds at [0.003, 0.03, 0.3, 3] µm; KCGS, 187 compounds at [0.1, 1] µm; LOPAC, 1277 compounds at [0.5, 3] µm; Prestwick, 1276 compounds at [1, 10] µm; TargetMol-330, 330 compounds at [0.01, 0.1, 1, 10] µm). (B) Representative images of multiplex cell painting assay screen performed across the three main GBM cellular subtypes: classical (GCGR-E13, GCGR-E28), proneural (GCGR-E31, GCGR-E34), and mesenchymal (GCGR-E21, GCGR-E57). The cell painting stains shown are Hoechst (blue), phalloidin/WGA (green), and endoplasmic reticulum (red). (C) Density plots over all six GBM cell lines of the percentage of nuclei counts after compound treatment with respect to the average DMSO negative control (100%) per plate. After removal of duplicates, the dataset contains 3561 unique compounds. Colours correspond to each library (panel A), and only the highest concentration per library is shown. Cell line sensitivity to the compounds is variable across the cell lines; the bimodality displayed by the TargetMol library reveals a larger fraction of compounds that affect cell viability as compared to the other four libraries. (D) Density plots of the TargetMol library screen at all concentrations of cell line GCGR-E57 (top) and of cell line GCGR-E21 (bottom). The black dotted line represents the average DMSO negative control nuclei count. As the concentration increases, a larger number of compounds affects cell viability.

    Article Snippet: The density of compounds' cell survival against DMSO control at the maximum concentration per library (C3L – 3 μM, KCGS – 1 μM, LOPAC – 3 μM, Prestwick – 10 μM, and TargetMol – 10 μM) shows a bimodal distribution for the TargetMol library, with more treatments that affect the cells' viability.

    Techniques: Sample Throughput, Phenotypic Assay, Screening, Derivative Assay, Multiplex Assay, Cell Painting, Negative Control, Concentration Assay, Sensitivity, Fluorescence Microscopy

    (a) Percent inhibition of entry into HEK 293T/T17 and (b) relative cell viability with 22f treatment against pseudotyped (PT) MLVs expressing NWA GPCs for JUNV, MACV, GTOV, or TCRV. Viral entry results represent the percent reduction in entry by 22f compared to the vehicle control. Cytotoxicity was determined in parallel by measuring the viability of treated cells using the CellTiter-Glo Luminescent Cell Viability Assay, with luminescence units normalized to the average vehicle control luminescence for each experiment. The 22f compound was well tolerated by cells, exhibiting a toxicity profile comparable to that of the ch128.1 positive-control antibody treatment. Data shown are the means ± SD from two separate experiments for each pseudotyped virus. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.

    Journal: ACS Infectious Diseases

    Article Title: Computer-Aided Discovery of Small-Molecule Inhibitors of Pathogenic New World Arenavirus Entry and Replication

    doi: 10.1021/acsinfecdis.6c00138

    Figure Lengend Snippet: (a) Percent inhibition of entry into HEK 293T/T17 and (b) relative cell viability with 22f treatment against pseudotyped (PT) MLVs expressing NWA GPCs for JUNV, MACV, GTOV, or TCRV. Viral entry results represent the percent reduction in entry by 22f compared to the vehicle control. Cytotoxicity was determined in parallel by measuring the viability of treated cells using the CellTiter-Glo Luminescent Cell Viability Assay, with luminescence units normalized to the average vehicle control luminescence for each experiment. The 22f compound was well tolerated by cells, exhibiting a toxicity profile comparable to that of the ch128.1 positive-control antibody treatment. Data shown are the means ± SD from two separate experiments for each pseudotyped virus. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.

    Article Snippet: Follow-up pseudotyped LASV 22f viral entry inhibition assays and parallel cell viability assays were performed similarly, with the addition of LHF-535 (TargetMol) as a positive control entry inhibitor for OW arenavirus entry, which was prepared in the same vehicle control solution.

    Techniques: Inhibition, Expressing, Control, Cell Viability Assay, Positive Control, Virus